Conferences and presentations

Our Adelphi Values PROVE and Patient-Centered Outcomes teams, alongside our sister company Adelphi Real World (who together make up the Powerhouse), are exhibiting at ISPOR in Copenhagen from 4th-6th November 2019.  Situated at location C3-060, we’re looking forward to a great three days! The PROVE team will… Read More

We are delighted that one of our posters at ISPOR EU has been peer reviewed and nominated as an award finalist. The poster titled ‘Europe-wide spread of carbapenem-resistant bacteria: Epidemiology and disease burden’ provides an overview of antibiotic resistance, a critical global health issue which is becoming increasingly prevalent across Europe… Read More

Adelphi Values | PROVE will be leading a podium presentation entitled ‘Differences in vaccine pricing between high‑income and low‑income markets’. Read More

Adelphi Values will be presenting and exhibiting at the 22nd Annual International Meeting of ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, which takes place from 20th‑24th May 2017 in Boston, MA, USA. Read More

Adelphi Values has been invited to present at the DIA’s Advancing the Science of Study Endpoints meeting to be held in Washington DC on Dec 5 and 6.  The purpose of the meeting is to assemble health outcomes experts to examine global strategies for selecting study endpoints and the impact… Read More

Meet our team presenting and exhibiting at the 19th Annual European Congress at ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, which takes place from 31st October to 2nd November 2016 in Vienna, Austria. Our workshop this year is entitled ‘Measuring multiple medication adherence – which… Read More

Thanks to all our clients and colleagues who visited our exhibition stand at ISPOR US which took place in Washington DC. As a result of your support, we have donated $500 to JDRF this year’s chosen charity. JDRF is a charitable organisation that supports sufferers and families… Read More

Meet the team presenting and exhibiting at the 21st Annual International Meeting of ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, taking place 23rd–25th May in Washington DC. Building on the success of previous ISPOR conferences, this year we will be hosting two workshops and presenting… Read More

We are honoured to have been invited to present at the 7th Annual Critical Path Institute Patient-Reported Outcome (PRO) Consortium Workshop to be held in Silver Spring, Maryland on 27th-28th April 2016. Rob Arbuckle, Managing Director of our UK Patient-Centered Outcomes practice, will be presenting two case studies as part… Read More

Increasing numbers of rare diseases are being recognised and more medicines to treat them are being developed. There are several unique challenges for developing evidence packages in rare diseases such as the paucity of information on patient populations, disease progression and appropriate Clinical Outcome Assessments (COAs). As with all clinical… Read More

This week we are attending the 6th Annual World Orphan Drug Congress in Geneva, Switzerland. We are pleased to be presenting a poster entitled ‘Development of patient-centred outcomes in rare diseases’ which will focus on the need for the development of new treatments for rare diseases and indications with orphan… Read More

We are exhibiting and presenting at the 18th Annual European Conference of ISPOR, the International Society for Pharmacoeconomics and Outcomes Research, which takes place from 9th-11th November 2015 in Milan, Italy. Representatives from each of our four practices and both the UK and US offices, will be attending the event. Read More

We are delighted to have recently been invited to present during the prestigious eCOA Forum Scientific Sessions which will be taking place at Oxford University, United Kingdom on 27th-29th October 2015.  Hosted by CRF Health, the conference brings together some of the healthcare industry’s leading professionals and will incorporate educational… Read More

On October 5th 2015, Alan Shields, PhD from Adelphi Values USA will be chairing a session entitled ‘Use and Usefulness of PRO Endpoints in Oncology Trials’ to be held from 12pm to 5pm.  This session is part of a broader DIA (Drug Information Association) conference in Bethesda, Maryland, USA entitled… Read More

In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers. Broad-based healthcare reforms, new pricing regulations, increasing tendering processes and emphasis on value-based assessment are all changing the game for pricing and reimbursement, while raising hurdles for market access. Read More

There is growing momentum among researchers, regulatory agencies, policy makers and payers towards a more patient-centric approach to health outcomes research and participation of patients in clinical trials. On 25 June 2015 at 3pm (GMT) PMGroup, in association with Adelphi Values, will host a free webinar showing how a more… Read More

Adelphi will be at ISPOR US in May, exhibiting at booths 411/413.  Senior representatives from Adelphi Values will be there alongside colleagues from our sister company Adelphi Real World. The theme for the conference this year is titled ‘Integrating Big Data, Patient Data, and Cost-Effectiveness into Clinical Practice: Promise and… Read More

Once again, Adelphi Values has been invited to participate in the C-Path Patient-Reported Outcome Consortium Workshop which will be taking place in Silver Spring, MD on 29-30th April 2015. Alan Shields, SVP, Endpoint Development & Outcomes, will participate in a discussion panel titled ‘Patient Reported Endpoints and the… Read More

It is with great pleasure we write that, once again, Adelphi Values will be exhibiting at ISPOR EU, Amsterdam, 8-12th November. We have a number of exciting things in store, including: A podium presentation titled ‘Elicitation of health state utilities associated with varying severities of flare in systemic lupus erythematosus’… Read More

On Wednesday 15th October, Eimear Nic Lochlainn and Jennifer Cook from the Adelphi Values Value Insight & Communication practice presented a master class in association with SMI at the European Pharmaceutical Pricing and Reimbursement conference in London. Targeted at pharmaceutical executives and senior market access professionals, the master class provided… Read More